Literature DB >> 1750797

Clinical aspects of systemic sclerosis (scleroderma).

R M Silver1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1750797      PMCID： PMC1033320          DOI： 10.1136/ard.50.suppl_4.854

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  69 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Diagnosis of Raynaud's phenomenon assisted by color charts.

Authors:  H R Maricq; M C Weinrich
Journal:  J Rheumatol       Date:  1988-03       Impact factor: 4.666

3.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.

Authors:  G Rittner; G Schwanitz; M P Baur; C M Black; K I Welsh; P Kühnl; C Rittner
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.

Authors:  B Waeber; M D Schaller; J P Wauters; H R Brunner
Journal:  Klin Wochenschr       Date:  1984-08-01

6.  Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma.

Authors:  C I Sandborg; M A Berman; B S Andrews; G R Mirick; G J Friou
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

7.  Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.

Authors:  A Kahan; J Y Devaux; B Amor; C J Menkès; S Weber; A Nitenberg; A Venot; F Guérin; M Degeorges; J C Roucayrol
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

8.  Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders.

Authors:  Z Y Chen; R M Silver; S K Ainsworth; R L Dobson; P Rust; H R Maricq
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

9.  HLA antigens, autoantibodies and clinical subsets in scleroderma.

Authors:  C M Black; K I Welsh; P J Maddison; M I Jayson; R M Bernstein
Journal:  Br J Rheumatol       Date:  1984-11

10.  Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.

Authors:  R M Silver; J F Metcalf; J H Stanley; E C LeRoy
Journal:  Arthritis Rheum       Date:  1984-11
View more
  16 in total

1.  Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.

Authors:  A C Gelber; S R Pillemer; B J Baum; F M Wigley; L K Hummers; S Morris; A Rosen; L Casciola-Rosen
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

Review 2.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

3.  Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.

Authors:  Lorenzo Beretta; Blanca Rueda; Maurizio Marchini; Alessandro Santaniello; Carmen P Simeón; Vicente Fonollosa; Monica Caronni; Raquel Rios-Fernandez; Patricia Carreira; Luis Rodriguez-Rodriguez; Antonia Moreno; Miguel A López-Nevot; Ana Escalera; Maria F González-Escribano; Javier Martin; Raffaella Scorza
Journal:  Rheumatology (Oxford)       Date:  2011-11-15       Impact factor: 7.580

4.  Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.

Authors:  Lorenzo Beretta; Monica Caronni; Massimo Raimondi; Alessandra Ponti; Tiziana Viscuso; Laura Origgi; Raffaella Scorza
Journal:  Clin Rheumatol       Date:  2006-04-14       Impact factor: 2.980

Review 5.  Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.

Authors:  Stefano Palmucci; Federica Galioto; Giulia Fazio; Agata Ferlito; Giovanna Cancemi; Alessia Di Mari; Gianluca Sambataro; Domenico Sambataro; Giovanni Zanframundo; Letizia Antonella Mauro; Pietro Valerio Foti; Carlo Vancheri; Antonio Basile
Journal:  Insights Imaging       Date:  2022-06-29

6.  Immunosuppression use in early systemic sclerosis may be increasing over time.

Authors:  Ryan Park; Tatiana Nevskaya; Murray Baron; Janet E Pope
Journal:  J Scleroderma Relat Disord       Date:  2021-03-29

7.  Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis.

Authors:  Pichaporn Sumphao-Ngern; Chingching Foocharoen; Watchara Boonsawat; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Uraiwan Sae-Oue; Sittichai Netwijitpan; Ratanavadee Nanagara
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

8.  A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation.

Authors:  Lorenzo Beretta; Marta Cossu; Maurizio Marchini; Francesca Cappiello; Andrea Artoni; Giovanna Motta; Raffaella Scorza
Journal:  Arthritis Res Ther       Date:  2008-09-01       Impact factor: 5.156

9.  Genome-wide DNA methylation analysis in blood cells from patients with Werner syndrome.

Authors:  T Guastafierro; M G Bacalini; A Marcoccia; D Gentilini; S Pisoni; A M Di Blasio; A Corsi; C Franceschi; D Raimondo; A Spanò; P Garagnani; F Bondanini
Journal:  Clin Epigenetics       Date:  2017-08-30       Impact factor: 6.551

10.  Idiopathic scrotal calcinosis - A case report.

Authors:  Ali Tareen; Rami Mossad Ibrahim
Journal:  Int J Surg Case Rep       Date:  2018-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.